• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗微管磺酰胺类药物:成熟药物类别与多效靶点的成功结合。

Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target.

机构信息

Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.

Facultad de Farmacia, Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.

出版信息

Med Res Rev. 2019 May;39(3):775-830. doi: 10.1002/med.21541. Epub 2018 Oct 25.

DOI:10.1002/med.21541
PMID:30362234
Abstract

Tubulin, the microtubules and their dynamic behavior are amongst the most successful antitumor, antifungal, antiparasitic, and herbicidal drug targets. Sulfonamides are exemplary drugs with applications in the clinic, in veterinary and in the agrochemical industry. This review summarizes the actual state and recent progress of both fields looking from the double point of view of the target and its drugs, with special focus onto the structural aspects. The article starts with a brief description of tubulin structure and its dynamic assembly and disassembly into microtubules and other polymers. Posttranslational modifications and the many cellular means of regulating and modulating tubulin's biology are briefly presented in the tubulin code. Next, the structurally characterized drug binding sites, their occupying drugs and the effects they induce are described, emphasizing on the structural requirements for high potency, selectivity, and low toxicity. The second part starts with a summary of the favorable and highly tunable combination of physical-chemical and biological properties that render sulfonamides a prototypical example of privileged scaffolds with representatives in many therapeutic areas. A complete description of tubulin-binding sulfonamides is provided, covering the different species and drug sites. Some of the antimitotic sulfonamides have met with very successful applications and others less so, thus illustrating the advances, limitations, and future perspectives of the field. All of them combine in a mechanism of action and a clinical outcome that conform efficient drugs.

摘要

微管、微管蛋白及其动态行为是最成功的抗肿瘤、抗真菌、抗寄生虫和除草药物靶点之一。磺胺类药物是具有临床、兽医和农业化学工业应用的典型药物。这篇综述从靶点及其药物的双重观点总结了这两个领域的现状和最新进展,特别关注结构方面。本文首先简要描述了微管蛋白的结构及其动态组装和分解为微管和其他聚合物。在微管密码中简要介绍了翻译后修饰和许多调节和调节微管生物学的细胞方法。接下来,描述了结构上有特征的药物结合位点、占据这些位点的药物以及它们诱导的作用,强调了高效力、选择性和低毒性的结构要求。第二部分首先总结了物理化学和生物性质的有利且高度可调的组合,使磺胺类药物成为具有代表性的特权支架的原型,在许多治疗领域都有代表。提供了与微管蛋白结合的磺胺类药物的完整描述,涵盖了不同的物种和药物靶点。一些抗有丝分裂的磺胺类药物已经得到了非常成功的应用,而其他的则不然,因此说明了该领域的进展、局限性和未来前景。它们都结合在作用机制和临床结果中,形成有效的药物。

相似文献

1
Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target.抗微管磺酰胺类药物:成熟药物类别与多效靶点的成功结合。
Med Res Rev. 2019 May;39(3):775-830. doi: 10.1002/med.21541. Epub 2018 Oct 25.
2
7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.7-芳酰基氨基吲哚啉-1-磺酰胺类作为一类新型强效抗微管蛋白药物。
J Med Chem. 2006 Nov 16;49(23):6656-9. doi: 10.1021/jm061076u.
3
Natural antitubulin agents: importance of 3,4,5-trimethoxyphenyl fragment.天然抗微管蛋白剂:3,4,5-三甲氧基苯基片段的重要性
Bioorg Med Chem. 2015 Feb 1;23(3):373-89. doi: 10.1016/j.bmc.2014.12.027. Epub 2014 Dec 20.
4
Structure-based discovery and rational design of microtubule-targeting agents.基于结构的微管靶向剂的发现和合理设计。
Curr Opin Struct Biol. 2024 Aug;87:102845. doi: 10.1016/j.sbi.2024.102845. Epub 2024 May 27.
5
Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.E7010与白藜芦醇新型缀合物作为微管蛋白聚合抑制剂的设计、合成及抗增殖活性
Org Biomol Chem. 2016 Jan 28;14(4):1382-94. doi: 10.1039/c5ob02022k. Epub 2015 Dec 16.
6
Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.苯磺酰胺衍生物作为有效的微管蛋白靶向剂的合成及抗癌评估
Eur J Med Chem. 2016 Oct 21;122:488-496. doi: 10.1016/j.ejmech.2016.07.002. Epub 2016 Jul 5.
7
Identification of a class of novel tubulin inhibitors.鉴定一类新型微管蛋白抑制剂。
J Med Chem. 2012 Apr 12;55(7):3425-35. doi: 10.1021/jm300100d. Epub 2012 Apr 2.
8
Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.近年来,针对秋水仙碱结合位点的三甲氧基苯基(TMP)基微管蛋白抑制剂取得了新进展。
Eur J Med Chem. 2018 May 10;151:482-494. doi: 10.1016/j.ejmech.2018.04.011. Epub 2018 Apr 5.
9
Indole based Tubulin Polymerization Inhibitors: An Update on Recent Developments.基于吲哚的微管蛋白聚合抑制剂:近期进展综述
Mini Rev Med Chem. 2016;16(18):1470-1499.
10
Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures.靶向秋水仙碱结合位点的微管蛋白抑制剂:优势结构视角
Future Med Chem. 2017 Oct;9(15):1765-1794. doi: 10.4155/fmc-2017-0100. Epub 2017 Sep 20.

引用本文的文献

1
A Novel Compound from the Phenylsulfonylpiperazine Class: Evaluation of In Vitro Activity on Luminal Breast Cancer Cells.一种新型苯磺酰基哌嗪类化合物:对腔上皮乳腺癌细胞体外活性的评估。
Molecules. 2024 Sep 20;29(18):4471. doi: 10.3390/molecules29184471.
2
Novel sulfonamides unveiled as potent anti-lung cancer agents tumor pyruvate kinase M2 activation.新型磺胺类药物被揭示为有效的抗肺癌药物,可激活肿瘤丙酮酸激酶M2。
RSC Med Chem. 2024 Jul 11;15(9):3070-3091. doi: 10.1039/d4md00367e. eCollection 2024 Sep 19.
3
Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition.
非毒性免疫抑制剂奋乃静及其类似物通过抑制微管蛋白显示抗肿瘤活性。
Int J Mol Sci. 2023 Dec 14;24(24):17474. doi: 10.3390/ijms242417474.
4
Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents.具有改善水溶性的强效且选择性的苯并噻唑类抗有丝分裂剂:作为新型抗癌剂的设计、合成与评估
Pharmaceutics. 2023 Jun 9;15(6):1698. doi: 10.3390/pharmaceutics15061698.
5
Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors.新型1,3,4-恶二唑衍生物作为潜在微管蛋白抑制剂的合成、分子对接研究及抗癌活性
Heliyon. 2023 Feb 8;9(2):e13460. doi: 10.1016/j.heliyon.2023.e13460. eCollection 2023 Feb.
6
Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors.基于药效团模型的虚拟筛选在新型抗有丝分裂微管蛋白抑制剂发现中的应用。
Comput Struct Biotechnol J. 2021 Aug 3;19:4360-4372. doi: 10.1016/j.csbj.2021.07.039. eCollection 2021.
7
Synthesis of triarylpyridines with sulfonate and sulfonamide moieties via a cooperative vinylogous anomeric-based oxidation.通过协同 vinylogous 端基基于糖的氧化合成带有磺酸酯和磺酰胺部分的三芳基吡啶。
Sci Rep. 2021 Aug 19;11(1):16846. doi: 10.1038/s41598-021-95830-w.
8
Methoxy and bromo scans on -(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line.-(5-甲氧基苯基)甲氧基苯磺酰胺的甲氧基和溴扫描揭示了具有强大细胞毒性的化合物,特别是对人乳腺癌 MCF7 细胞系。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1029-1047. doi: 10.1080/14756366.2021.1925265.
9
Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy.微管去稳定磺胺类药物作为紫杉烷类化疗的替代药物。
Int J Mol Sci. 2021 Feb 14;22(4):1907. doi: 10.3390/ijms22041907.
10
The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.掩蔽极地集团公司(MPGI)药物设计策略:氮取代对康普瑞汀和异康普瑞汀微管抑制剂的影响。
Molecules. 2019 Nov 26;24(23):4319. doi: 10.3390/molecules24234319.